ROR1 and B-cell chronic lymphocytic leukemia: KAN043983 is a small oral molecule that inhibits Wnt5a-induced ROR1 phosphorylation in CLL cells (Ghaderi et al., 2020; Sheetz et al., 2020; Kipps, 2022).